Phosphatidylethanolamines
"Phosphatidylethanolamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.
| Descriptor ID |
D010714
|
| MeSH Number(s) |
D10.570.755.375.760.400.840
|
| Concept/Terms |
Phosphatidylethanolamines- Phosphatidylethanolamines
- Ethanolamineglycerophospholipids
- Cephalins
- Ethanolamine Phosphoglycerides
- Phosphoglycerides, Ethanolamine
|
Below are MeSH descriptors whose meaning is more general than "Phosphatidylethanolamines".
Below are MeSH descriptors whose meaning is more specific than "Phosphatidylethanolamines".
This graph shows the total number of publications written about "Phosphatidylethanolamines" by people in this website by year, and whether "Phosphatidylethanolamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 8 | 1 | 9 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 1 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 3 | 3 |
| 2013 | 2 | 1 | 3 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphatidylethanolamines" by people in Profiles.
-
Phosphatidylserine and Phosphatidylethanolamine Asymmetry Have a Negligible Effect on the Global Structure, Dynamics, and Interactions of the KRAS Lipid Anchor. J Phys Chem B. 2022 06 23; 126(24):4491-4500.
-
Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients. Metabolomics. 2019 05 03; 15(5):74.
-
Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus. 2018 12; 4(6):907-915.
-
Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments. Pediatr Blood Cancer. 2014 Feb; 61(2):238-44.
-
RNA replicon delivery via lipid-complexed PRINT protein particles. Mol Pharm. 2013 Sep 03; 10(9):3366-74.
-
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology. 2013 Oct; 58(4):1296-305.
-
Intravenous delivery of targeted liposomes to amyloid-? pathology in APP/PSEN1 transgenic mice. PLoS One. 2012; 7(10):e48515.
-
Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2013 Mar; 54(3):535-40.
-
Evaluation of asymmetric immunoliposomal nanoparticles for cellular uptake. J Microencapsul. 2013; 30(1):55-63.
-
Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery. J Control Release. 2011 Oct 30; 155(2):317-25.